Piramal's revenues up 12% in second quarter
This article was originally published in Scrip
Executive Summary
Piramal Healthcare has reported a 12% increase in consolidated revenues to Rs10 billion ($215 million) for the second quarter ended September 30th, led by growth in its domestic formulations business. Net profit increased by 45% to Rs1 billion, while operating profit was up by 26% to Rs1.8 billion.